Add Yahoo as a preferred source to see more of our stories on Google. For years, researchers have wondered whether these medicines protect the heart in the same way. (CREDIT: CC BY-SA 4.0) ...

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control and ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Learn why GLP-1 use isn’t included in how experts define type 2 diabetes remission despite the drugs’ ability to help manage blood sugar and reduce a person’s A1C.

Eli Lilly's GLP-1 drug tirzepatide shows greater weight loss compared to Novo Nordisk's semaglutide, but with more muscle and connective tissue loss. Study findings reveal tirzepatide users experience ...

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the ...

No significant increase in hazard ratios seen for GI events for semaglutide vs dulaglutide, tirzepatide vs dulaglutide, tirzepatide vs semaglutide. HealthDay News For patients with type 2 diabetes ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...